Change Agents Corporation appointed Luisa Ingargiola, the company's current Chief Strategy Officer, as its principal executive officer effective November 4, 2026. She will serve in this role until a new Chief Executive Officer is appointed and will not receive additional compensation for the service. The company also issued a $250,000 promissory note to Harllon Holdings LLC and issued 150,000 shares to consultants for services rendered.
Change Agents Corporation appointed Eric Weisblum as an independent director to its board of directors, effective October 12, 2026. Mr. Weisblum, who is currently the CEO of Silo Pharma Inc, will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees.
Meng Li has resigned from her roles as Interim CEO, COO, and Secretary of Change Agents Corporation, effective October 8, 2026. Her departure is intended to facilitate the company's preparation for a potential acquisition in the drone defense industry, and the Board has initiated a search for a replacement from the global defense and AI sectors.